RushPR News – Lifestyle
Author:
OKYO Pharma LTD
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
May 19, 2026
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
April 29, 2026
OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
April 7, 2026
OKYO Pharma Announces Chairman and Founder Acquires Shares
March 19, 2026
OKYO Pharma Announces Director Acquires Shares
March 19, 2026
OKYO Pharma Announces Chief Development Officer and Director Acquires Shares
March 19, 2026
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
March 18, 2026